Monsenso

Changes in Monsenso’s revenue expectations for 2021

13.9.2021 12:02:11 CEST | Monsenso | Company Announcement

Company announcement no. 16-2021

Copenhagen, 2021.09.13

Monsenso changes its expectations to revenue in 2021 to DKK 7-8m.

Despite new orders in Denmark as well as in the UK, two new larger customer cases will not be closed as expected in the company’s favour this year. The expectations for revenue in the current financial year are therefore adjusted to DKK 7-8m against previously announced DKK 9-10m. Due to Covid-19 and the fact that revenue is still dependent on the progress in a number of large customer projects, expectations are subject to uncertainty.

Expectations to EBITDA is adjusted to DKK -5.5m to -6.5m from previously DKK -5m to -6m. The relatively modest change in EBITDA is caused by cost reduction and postponement.

The markets for digital mental health and real-world data collection continue to be very attractive and Monsenso retains its ambitions to create international growth. With expansion of the technical and commercial organisation, including establishing a sales organisation in the UK, Monsenso is currently building the required sales pipeline that is the foundation for future growth.

Any inquiries regarding this notice should be directed to:

Monsenso

CEO
Thomas Lethenborg
Tlf. +45 21 29 88 27
E-mail: lethenborg@monsenso.com 

Chairman of the board
Maria Hjorth
Tel. +45 25 55 63 39
E-mail: maria.hjorth@gmail.com

Certified Adviser

Norden CEF ApS
John Norden
Tlf. +45 20 72 02 00
E-mail: jn@nordencef.dk

About Monsenso

Monsenso is an innovative technology company offering a digital health solution for mental health and behavioral disorders. Our mission is to help provide better mental health to more people at lower costs. Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit  www.monsenso.com

Alternative languages

Attachments

Subscribe to our company announcements

Keep up to date with our company announcements by subscribing.

Visit our pressroom and see more company announcements from us.

Our pressroom